Thai Red Cross AIDS Research Center
Bangkok, 10330, Thailand
NCT Number: NCT03778892
A randomized controlled clinical trial looking at the effect of use of a mobile phone application in addition to standard care compared to standard care alone at a youth-friendly clinic in young men who have sex with men and transgender women aged between 15-19 years at risk of HIV on PrEP adherence.
Looking for future studies?
Notify Me15 year–19 year
Male
Interventional
Not applicable
Bangkok, 10330, Thailand
OBJECTIVES
Primary Objectives:
To study PrEP adherence in adolescent MSM who are at high risk of HIV acquisition.
Secondary Objectives:
To study
HYPOTHESES:
RESEARCH DESIGN:
Randomised control trial, behavioural intervention
RESEARCH METHODOLOGY
Youth-focused counselling Counsellors will provide counselling that is friendly, non-judgmental and utilize motivational interviewing techniques where sessions are more collaborative rather than didactic.
Mobile Phone Application
Participants will be followed up at months 1, 3 and 6. At each visit, participants will complete a questionnaire on drug adherence and sexual health risk behaviours.
STI testing will be done as an indirect marker of condom use at visits 1 and 6. This will involve blood testing for syphilis serology and nucleic acid amplification testing for gonorrhea, and chlamydia on swab samples.
HIV testing will be done at all visits. TFV-DP DBS will be done at months 1, 3 and 6 to look at correlation of self-reported and actual measured PrEP compliance.
Drug Concentrations will be measured using the TFV-DP DBS at the Program for HIV Prevention and Treatment (PHPT), Chiang Mai. TFV-DP DBS levels ≥ 700 fmol/punch will be taken as adherence
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mobile phone application with weekly input channels for PrEP use, condom use, number of sex partners and sex acts and a calculation of self-HIV risk feedback scoring. Scoring system for attendance of visits, normal blood tests and use of application. Points redeemable for cash. Optional alarm system to remind to take medications and attend visits.
Time frame: Weekly self-reported adherence for a period of 6 months following randomization
Self-Reported Adherence
Time frame: Measured at month 3 (measure of 17 day half life of TDF-DP)
Measured Serum TDF-DP Level (from dried blood spots)
Time frame: Measured at month 6 (measure of 17 day half life of TDF-DP)
Measured Serum TDF-DP Level (from dried blood spots)
Time frame: duration of study (6 months)
seroconversion rates whilst on PrEP during study
Time frame: duration of study (6 months)
Rates of Urethral Neisseria gonorrhea via Nucleic Acid Amplification Screening (NAAT) urine testing
Time frame: duration of study (6 months)
Composite calculated score of risk taking based on self-reported condom use, PrEP tablets taking, number of sexual partners in preceding one month. Scores will equate to risk levels of low, medium, high and very high.
Time frame: duration of study (6 months)
Rates of Anal Neisseria gonorrhea via Nucleic Acid Amplification Screening (NAAT) from anal swab samples
Time frame: duration of study (6 months)
Rates of Urethral Chlamydia trachomatis via Nucleic Acid Amplification Screening (NAAT) urine testing
Time frame: duration of study (6 months)
Rates of Anal Chlamydia trachomatis via Nucleic Acid Amplification Screening (NAAT) from anal swab samples
Time frame: duration of study (6 months)
Rates of positive treponemal blood tests
Time frame: At initial project visit (month 0)
Rates of positive HbsAg blood tests
Chulalongkorn University
Other
Acronym: YouthPrEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03640325
Adherence, Medication, Adolescent Behavior
Birmingham, Alabama, United States
View Trial DetailsNCT03771638
Adherence, Medication, Behavior
San Francisco, California, United States
View Trial DetailsNCT03387462
Adherence, Medication, Behavior
San Francisco, California, United States
View Trial DetailsNCT04868383
Adherence, Medication, Behavior
Charlottesville, Virginia, United States
View Trial Details